Halozyme Therapeutics, Inc. (HALO)

The Duckhorn Portfolio Market Cap

Halozyme Therapeutics has a market cap or net worth of $7.36 billion as of August 8, 2025. Its market cap has increased by 4.81% in one year.

• Market Cap: 7.36B
• Enterprise Value: 8.35B
• 1-Year Change: 4.81%
• Ranking: #1052
• Category: Mid-Cap
• Stock Price: $62.90

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $7.36B, an increase of 90,729.15%. That is a compound annual growth rate of 37.46%.

Market Cap History

Date	Market Cap	% Change
Aug 8, 2025	7.36B	20.95%
Dec 31, 2024	6.08B	24.59%
Dec 29, 2023	4.88B	-36.54%
Dec 30, 2022	7.69B	35.91%
Dec 31, 2021	5.66B	-1.95%
Dec 31, 2020	5.77B	122.23%
Dec 31, 2019	2.60B	22.85%
Dec 31, 2018	2.11B	-26.67%
Dec 29, 2017	2.88B	125.43%
Dec 30, 2016	1.28B	-42.33%
Dec 31, 2015	2.22B	83.35%
Dec 31, 2014	1.21B	-29.21%
Dec 31, 2013	1.71B	126.01%
Dec 31, 2012	756.30M	-23.30%
Dec 30, 2011	986.10M	23.98%
Dec 31, 2010	795.40M	47.84%
Dec 31, 2009	538.00M	17.96%
Dec 31, 2008	456.10M	-17.36%
Dec 31, 2007	551.90M	6.38%
Dec 29, 2006	518.80M	469.48%
Dec 30, 2005	91.10M	-13.07%
Dec 31, 2004	104.80M	1,193.83%
Mar 16, 2004	8.10M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	561.67B
Johnson & Johnson	417.44B
AbbVie	349.87B
Abbott Laboratories	233.71B
AstraZeneca	227.85B
UnitedHealth Group	227.59B
Novartis AG	225.61B
Novo Nordisk	224.34B